down arrow

Gennex Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE509C01026
  • NSEID:
  • BSEID: 531739
INR
13.30
0.12 (0.91%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.73 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

13.1013.50

52 Week

11.4129.00
Valuation
Technical
Day's Volume

CASH

1.73 lacs (-47.28%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

18.42%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor Management Efficiency with a low ROE of 9.09%

  • The company has been able to generate a Return on Equity (avg) of 9.09% signifying low profitability per unit of shareholders funds
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Healthy long term growth as Operating profit has grown by an annual rate 48.58%

 
4

With a growth in Net Sales of 87.05%, the company declared Very Positive results in Dec 24

5

Stock is technically in a Bearish range

6

With ROE of 9.8, it has a Very Attractive valuation with a 1.7 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 303 Cr (Micro Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.13

stock-summary
Return on Equity

9.80%

stock-summary
Price to Book

1.72

Revenue and Profits (1 Year):
Net Sales:
40 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-38.51%
0%
-38.51%
1 Year
-21.86%
0%
-21.86%
2 Years
116.61%
0%
116.61%
3 Years
56.65%
0%
56.65%
4 Years
180.59%
0%
180.59%
5 Years
340.4%
0%
340.4%

Gennex Lab. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
16.55%
EBIT Growth (5y)
48.58%
EBIT to Interest (avg)
6.44
Debt to EBITDA (avg)
1.26
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.01
Tax Ratio
13.89%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
12.19%
ROE (avg)
9.09%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
33
Price to Book Value
1.72
EV to EBIT
10.94
EV to EBITDA
10.03
EV to Capital Employed
1.83
EV to Sales
1.98
PEG Ratio
0.37
Dividend Yield
NA
ROCE (Latest)
15.15%
ROE (Latest)
9.80%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Premier Fiscal Services Private Limited (16.5%)

Highest Public shareholder

Jms Mines & Minerals Private Limited (3.47%)

Individual Investors Holdings

60.53%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 87.05% vs 46.21% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 79.15% vs 139.81% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.01",
          "val2": "21.39",
          "chgp": "87.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.16",
          "val2": "4.79",
          "chgp": "49.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.84",
          "val2": "0.83",
          "chgp": "1.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.64",
          "val2": "2.59",
          "chgp": "79.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.99%",
          "val2": "25.03%",
          "chgp": "-6.04%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 85.46% vs 1.38% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 69.43% vs 228.89% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "64.17",
          "val2": "34.60",
          "chgp": "85.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.15",
          "val2": "10.87",
          "chgp": "30.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.57",
          "val2": "1.68",
          "chgp": "-6.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.03",
          "val2": "5.92",
          "chgp": "69.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.63%",
          "val2": "31.90%",
          "chgp": "-8.27%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 86.07% vs 14.83% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 72.39% vs 195.49% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "104.18",
          "val2": "55.99",
          "chgp": "86.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.31",
          "val2": "15.66",
          "chgp": "36.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.41",
          "val2": "2.51",
          "chgp": "-3.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.67",
          "val2": "8.51",
          "chgp": "72.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.45%",
          "val2": "27.97%",
          "chgp": "-7.52%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 31.73% vs 11.12% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 150.41% vs 25.51% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "91.62",
          "val2": "69.55",
          "chgp": "31.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.94",
          "val2": "8.64",
          "chgp": "153.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.08",
          "val2": "1.35",
          "chgp": "128.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.32",
          "val2": "4.92",
          "chgp": "150.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.30%",
          "val2": "13.17%",
          "chgp": "12.13%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
40.01
21.39
87.05%
Operating Profit (PBDIT) excl Other Income
7.16
4.79
49.48%
Interest
0.84
0.83
1.20%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4.64
2.59
79.15%
Operating Profit Margin (Excl OI)
18.99%
25.03%
-6.04%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 87.05% vs 46.21% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 79.15% vs 139.81% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
64.17
34.60
85.46%
Operating Profit (PBDIT) excl Other Income
14.15
10.87
30.17%
Interest
1.57
1.68
-6.55%
Exceptional Items
0.00
0.00
Consolidate Net Profit
10.03
5.92
69.43%
Operating Profit Margin (Excl OI)
23.63%
31.90%
-8.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 85.46% vs 1.38% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 69.43% vs 228.89% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
104.18
55.99
86.07%
Operating Profit (PBDIT) excl Other Income
21.31
15.66
36.08%
Interest
2.41
2.51
-3.98%
Exceptional Items
0.00
0.00
Consolidate Net Profit
14.67
8.51
72.39%
Operating Profit Margin (Excl OI)
20.45%
27.97%
-7.52%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 86.07% vs 14.83% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 72.39% vs 195.49% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
91.62
69.55
31.73%
Operating Profit (PBDIT) excl Other Income
21.94
8.64
153.94%
Interest
3.08
1.35
128.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
12.32
4.92
150.41%
Operating Profit Margin (Excl OI)
25.30%
13.17%
12.13%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 31.73% vs 11.12% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 150.41% vs 25.51% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Gennex Laboratories Ltd stock-summary
stock-summary
Gennex Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985. The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates. It is engaged in manufacturing and marketing of bulk drugs and intermediates.
Company Coordinates stock-summary
Company Details
Survey No 133 Bollaram, Jinnaram Mandal Medak Telangana : 502325
stock-summary
Tel: 91-8458-279406/279516
stock-summary
http://www.gennexlab.com
stock-summary
Registrar Details
R&D Infotech Pvt Ltd, 7 A Beltala Road, Kolkata
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."